Ulcerative Colitis Global Clinical Trials Review, H2, 2013

163 pages report Published in
Pharmaceuticals
Publisher: GlobalData

arrowFor This Report

GlobalData’s clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2013” provides data on the Ulcerative Colitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ulcerative Colitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ulcerative Colitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents


Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Ulcerative Colitis 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by BRIC Nations 16

Clinical Trials by G7 Nations 17

Clinical Trials in G7 Nations by Trial Status 18

Clinical Trials by E7 Nations 19

Clinical Trials in E7 Nations by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Unaccomplished Trials of Ulcerative Colitis 24

Subjects Recruited Over a Period of Time 30

Prominent Sponsors 31

Top Companies Participating in Ulcerative Colitis Therapeutics Clinical Trials 33

Prominent Drug Comparison 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

Pfizer Inc. 36

Clinical Trial Overview of Pfizer Inc. 36

Salix Pharmaceuticals Ltd. 37

Clinical Trial Overview of Salix Pharmaceuticals Ltd. 37

Shire Plc 38

Clinical Trial Overview of Shire Plc 38

Zeria Pharmaceutical Co Ltd 39

Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 39

Ferring Pharmaceuticals, Inc. 40

Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 40

AbbVie Inc. 41

Clinical Trial Overview of AbbVie Inc. 41

Dr. Falk Pharma GmbH 42

Clinical Trial Overview of Dr. Falk Pharma GmbH 42

Johnson & Johnson 43

Clinical Trial Overview of Johnson & Johnson 43

GlaxoSmithKline plc 44

Clinical Trial Overview of GlaxoSmithKline plc 44

Isis Pharmaceuticals, Inc. 45

Clinical Trial Overview of Isis Pharmaceuticals, Inc. 45

Santarus, Inc. 46

Clinical Trial Overview of Santarus, Inc. 46

Warner Chilcott Plc 47

Clinical Trial Overview of Warner Chilcott Plc 47

Tillotts Pharma AG 48

Clinical Trial Overview of Tillotts Pharma AG 48

Merck & Co., Inc. 49

Clinical Trial Overview of Merck & Co., Inc. 49

Bristol-Myers Squibb Company 50

Clinical Trial Overview of Bristol-Myers Squibb Company 50

Millennium Pharmaceuticals, Inc. 51

Clinical Trial Overview of Millennium Pharmaceuticals, Inc. 51

Warner Chilcott Company, Inc. 52

Clinical Trial Overview of Warner Chilcott Company, Inc. 52

Am-Pharma B.V. 53

Clinical Trial Overview of Am-Pharma B.V. 53

Otsuka Holdings Co., Ltd. 54

Clinical Trial Overview of Otsuka Holdings Co., Ltd. 54

Ajinomoto Pharmaceuticals Co., Ltd. 55

Clinical Trial Overview of Ajinomoto Pharmaceuticals Co., Ltd. 55

Clinical Trial Overview of Top Institutes / Government 56

Keio University 56

Clinical Trial Overview of Keio University 56

Hyogo College Of Medicine 57

Clinical Trial Overview of Hyogo College Of Medicine 57

Academic Medical Centre 58

Clinical Trial Overview of Academic Medical Centre 58

Saitama Medical University 59

Clinical Trial Overview of Saitama Medical University 59

Tokyo Medical and Dental University 60

Clinical Trial Overview of Tokyo Medical and Dental University 60

Vanderbilt University 61

Clinical Trial Overview of Vanderbilt University 61

University of Washington 62

Clinical Trial Overview of University of Washington 62

Kyoto University 63

Clinical Trial Overview of Kyoto University 63

University Hospitals of Leicester NHS Trust 64

Clinical Trial Overview of University Hospitals of Leicester NHS Trust 64

VU University Medical Center 65

Clinical Trial Overview of VU University Medical Center 65

Boston Children's Hospital 66

Clinical Trial Overview of Boston Children's Hospital 66

University of Heidelberg 67

Clinical Trial Overview of University of Heidelberg 67

Indiana University 68

Clinical Trial Overview of Indiana University 68

University Hospitals of Cleveland 69

Clinical Trial Overview of University Hospitals of Cleveland 69

University of Pittsburgh 70

Clinical Trial Overview of University of Pittsburgh 70

Hvidovre University Hospital 71

Clinical Trial Overview of Hvidovre University Hospital 71

The Medical University of Graz 72

Clinical Trial Overview of The Medical University of Graz 72

Asan Medical Center 73

Clinical Trial Overview of Asan Medical Center 73

Postgraduate Institute of Medical Education and Research 74

Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 74

The University of Chicago 75

Clinical Trial Overview of The University of Chicago 75

Five Key Clinical Profiles 76

Appendix 160

Abbreviations 160

Definitions 160

Research Methodology 161

Secondary Research 161

About GlobalData 162

Contact Us 162

Disclaimer 162

Source 163


List of Tables


Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10

Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11

Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12

Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries, 2013* 13

Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14

Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15

Ulcerative Colitis Therapeutics Clinical Trials, BRIC Countries, 2013* 16

Ulcerative Colitis Therapeutics Clinical Trials, G7 Countries, 2013* 17

Ulcerative Colitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18

Ulcerative Colitis Therapeutics Clinical Trials, E7 Countries, 2013* 19

Ulcerative Colitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23

Ulcerative Colitis Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24

Ulcerative Colitis Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25

Ulcerative Colitis Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26

Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30

Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 32

Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 34

Ulcerative Colitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 36

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals Ltd., 2013* 37

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2013* 38

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2013* 39

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, Inc., 2013* 40

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013* 41

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2013* 42

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 43

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 44

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2013* 45

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Santarus, Inc., 2013* 46

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Warner Chilcott Plc, 2013* 47

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tillotts Pharma AG, 2013* 48

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 49

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 50

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Millennium Pharmaceuticals, Inc., 2013* 51

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Warner Chilcott Company, Inc., 2013* 52

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Am-Pharma B.V., 2013* 53

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2013* 54

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajinomoto Pharmaceuticals Co., Ltd., 2013* 55

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2013* 56

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2013* 57

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013* 58

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2013* 59

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Medical and Dental University, 2013* 60

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 61

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2013* 62

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013* 63

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2013* 64

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2013* 65

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2013* 66

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2013* 67

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2013* 68

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Cleveland, 2013* 69

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 70

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2013* 71

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2013* 72

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2013* 73

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2013* 74

Ulcerative Colitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 75


List of Figures


Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10

Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11

Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12

Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13

Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14

Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15

Ulcerative Colitis Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16

Ulcerative Colitis Therapeutics Clinical Trials, G7 Countries (%), 2013* 17

Ulcerative Colitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18

Ulcerative Colitis Therapeutics Clinical Trials, E7 Countries (%), 2013* 19

Ulcerative Colitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23

Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 30

Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31

Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33

Ulcerative Colitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 35

GlobalData Methodology 161


Related Reports

  • Eisenmenger Syndrome Global Clinical Trials Review, H2, 2014GlobalData's clinical trial report, "Eisenmenger Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Eisenmenger Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Eisenmenger Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, […]
  • Convulsions Global Clinical Trials Review, H1, 2014GlobalData's clinical trial report, "Convulsions Global Clinical Trials Review, H1, 2014" provides data on the Convulsions clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Convulsions. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence […]
  • Degenerative Scoliosis Global Clinical Trials Review, H1, 2014GlobalData's clinical trial report, "Degenerative Scoliosis Global Clinical Trials Review, H1, 2014" provides data on the Degenerative Scoliosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Degenerative Scoliosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their […]
  • Thrombophlebitis Global Clinical Trials Review, H2, 2014GlobalData's clinical trial report, "Thrombophlebitis Global Clinical Trials Review, H2, 2014" provides data on the Thrombophlebitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thrombophlebitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial […]
  • Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014GlobalData's clinical trial report, "Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014" provides data on the Dysgeusia (Taste Disorders) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysgeusia (Taste Disorders). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical […]